Delivery Order SPE2DB24D1205-SPE2DB24FCSKX
Award Date
7/2/24
Potential Completion Date
7/24/24
Potential Value
$6.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a Delivery Order valued at $4,863.90 for the supply of the pharmaceutical product KEDRAB 150 U/ML VL 1S. The contract was awarded on May 31, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of medical products and services to the Department of Defense (DoD), with an ultimate completion date of June 24, 2024. This award is associated with Amerisourcebergen's larger...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the pharmaceutical product KEDRAB, a 1,500 unit/10 ML vial of which is valued at $3,248.74. The award was made by the Defense Logistics Agency (DLA), a defense agency, on July 1, 2024, with a completion date of July 23, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This single-award IDC...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $8,121.85 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 1,500 units of the pharmaceutical product KEDRAB (10 ml vials). The contract has a firm fixed-price pricing type and an ultimate completion date of July 11, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $6,497.52 Firm Fixed Price Delivery Order for the supply of 1,500 units of the pharmaceutical product KEDRAB (1,500 Unit/10 ML Vial 10ML). The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of Amerisourcebergen's federal contracting activities. Amerisourcebergen, a large pharmaceutical distributor, has been awarded numerous Indefinite Delivery...
This federal contract award was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply the medical product KEDRAB 150 U/ML VL 1S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $7,782.24 and was awarded on a Firm Fixed Price basis. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 through December 2025. This single-award IDC...
This federal contract award, valued at $1,945.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of September 25, 2024. This award does not have a set-aside designation. AmerisourceBergen Drug Corp holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4,563,471,849 units of the pharmaceutical product KEDRAB 300 UNIT/2 ML VIAL 2ML. The contract has a potential value of $3,242.70 and a completion date of February 20, 2024. This award is not associated with any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor for this delivery order,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,083.12 firm fixed-price delivery order is for the supply of 1,500 units of the medication KEDRAB 10 ML vial. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,624.37, is for the delivery of 1,500 units of the pharmaceutical product KEDRAB (10 mL vial). The contract has a period of performance through May 28, 2024 and is structured as a firm fixed-price delivery order. This contract award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $16,243.70 firm fixed price contract is for the supply of 1,500 units of the medication KEDRAB (10 mL vial) to support federal healthcare programs. The contract has an ultimate completion date of October 18, 2024 and does not utilize any set-aside designations. AmerisourceBergen has been awarded other significant Indefinite...